Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine + ketamine + midazolam versus morphine + ketamine + diphenhydramine for acute postoperative pain
IRCT20130304012695N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in postoperative pain comparing Morphine + ketamine + midazolam with Morphine + ketamine + diphenhydramine (2 arms). Primary endpoints: Pain severity, Heart rate and 2 more. Started Feb 2019; status: completed.
02
Drugs
morphineketaminemidazolamdiphenhydramine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20130304012695N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130304012695N2.